Related Experiment Videos
[Anxiety and depression in bronchial asthma]
K Badura1, Z Brzoza, P Gorczyca
1Katedry i Oddziału Klinicznego Psychiatrii w Tarnowskich Górach.
Psychiatria Polska
|February 15, 2002
Summary
Patients with bronchial asthma experience higher rates of depression and anxiety compared to healthy individuals. Nonatopic asthma patients showed more severe symptoms than atopics.
Area of Science:
- Psychiatry
- Pulmonology
- Clinical Psychology
Context:
- Bronchial asthma is a chronic respiratory condition affecting millions globally.
- Mental health comorbidities like anxiety and depression are increasingly recognized in chronic illness management.
- Understanding the psychological impact on asthma patients is crucial for comprehensive care.
Purpose:
- To determine the prevalence and clinical course of depression and anxiety in patients with bronchial asthma.
- To compare anxiety and depression levels between atopic and nonatopic asthma patients.
- To assess the differences in mental health symptoms between asthmatics and a healthy control group.
Summary:
- This study investigated depression and anxiety in 57 mild-to-moderate bronchial asthma patients and 53 controls using Beck Depression Inventory (BDI), State-Trait Anxiety Inventory (STAI), and Hospital Anxiety and Depression Scale (HADS).
- Results indicated significantly higher levels and prevalence of anxiety and depression in both asthmatic groups compared to controls.
- Nonatopic asthma patients exhibited greater depression and anxiety symptoms than atopic patients, with overall symptoms being mild to moderate.
Impact:
- Highlights the significant psychological burden associated with bronchial asthma.
- Suggests a need for routine mental health screening in asthma patients.
- Informs targeted interventions for nonatopic asthma patients who may be at higher risk for depression and anxiety.